Twice weekly pulse and daily continuous‐dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
Kathryn C. Arbour; Mark G. Kris; Gregory J. Riely; Ai Ni; Kathryn Beal; Mariza Daras; Sara A. Hayes; Robert J. Young; Christopher R. Rodriguez; Linda Ahn; William Pao; Helena A. Yu
Author Information: Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.